Modifying Antiretroviral Therapy in Virologically Suppressed HIV-Infected Patients
Summary
- Patients switched to the single-tablet regimen of emtricitabine/rilpivirine/tenofovir experienced significant mean reductions in serum lipids compared with patients continuing on their boosted PI–based regimens[Palella 2014]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content